Status:
COMPLETED
Therapeutic Potential of Stem Cell Conditioned Medium on Chronic Ulcer Wounds
Lead Sponsor:
Sukma Skin Treatment
Collaborating Sponsors:
Stem Cell and Cancer Institute, Kalbe Farma Tbk
PT Pharma Metric Labs
Conditions:
Chronic Ulcer
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
Chronic wounds (CW) still represents a heavy burden to many patients and health care institution. Despite the most recent advances in wound management, up to 50% of chronic wounds still fail to heal. ...
Detailed Description
Treatment for chronic wound healing has become a great challenge in medical world. The incidence of chronic non healing wounds continues to increase and the classical method for wound healing therapy ...
Eligibility Criteria
Inclusion
- Subjects with chronic skin ulcer that had received therapy for more than 1 month but there were no improvements
Exclusion
- Respondent who refused to be the subject of this research
- ulcer size \>10 x 15 cm
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 10 2020
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT04134676
Start Date
June 1 2019
End Date
June 10 2020
Last Update
June 22 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayapada Hospital
Tangerang, Banten, Indonesia, 15117
2
Indra Clinic
Tangerang, Banten, Indonesia, 15710
3
Sukma Cliniq
Tangerang, Banten, Indonesia, 15810